Mary Pardhe

Principal investigator, leads VAXSYNA, INC..

BiotechFounder

Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.

2022First federal award

$437KFederal grants as PI2 awards

0Patents grantedNone matched

0PapersOpenAlex

Career record

Federal awards and patents by year

20222022

AwardsPatents

Federal awards as principal investigator

2 awards · $437K

Date	Agency	Award	Amount	Company
Sep 19, 2022	NIH	STTR Phase I Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus	$121K	VAXSYNA, INC.
Mar 24, 2022	NIH	STTR Phase I Low cost, Broad Spectrum Cancer Vaccine Targeting Human Papillomavirus	$316K	VAXSYNA, INC.

Among 4,078 researchers in Biotech

Peer ranks

Federal funding#2,573

Awards as PI#1,252

Patents#273

From filings, awards and patents

Companies

VAXSYNA, INC.Leads (SEC Form D) · Biotech

Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.